AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Global Partners LP

$50.87 +$8.61 (+20.37%)
NYSE · 15 Sep 2026 20:00 UTC
Previous Close
$51.12
Day Range
$50.48$51.45
Year Range
$39.58$54.29
Market Cap
1.73B
AVG Volume
97.19K
Trailing/Forward PE
10.32/13.39
PEG ratio
-0.29
Dividend Yield
6.02%
Next Earnings Date
2026-11-06
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
010B20B30B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q221.46B
26 Q119.29B
25 Q418.56B
25 Q318.1B
25 Q217.83B
25 Q117.61B
24 Q417.16B
24 Q317.39B
24 Q217.19B
24 Q116.61B
Net Income (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2172.42M
26 Q1129.69M
25 Q483.63M
25 Q387.36M
25 Q2109.06M
25 Q1131.98M
24 Q4104.56M
24 Q3135.98M
24 Q2116.86M
24 Q1114.74M
Operating Income (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2537.31M
26 Q1488.28M
25 Q4192.06M
25 Q3233.7M
25 Q2255.74M
25 Q1281.27M
24 Q4251.49M
24 Q3275.04M
24 Q2239.56M
24 Q1218.37M
EBITDA (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2406.33M
26 Q1357.99M
25 Q4378.79M
25 Q3379.34M
25 Q2401.26M
25 Q1424.31M
24 Q4389.39M
24 Q3405.66M
24 Q2363.26M
24 Q1335.16M
Cash Flows (USD) · TTM
-400M-200M0200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2199.43M
26 Q1131.7M
25 Q4198.79M
25 Q3-63.79M
25 Q232.55M
25 Q1-157.61M
24 Q4-287.45M
24 Q3-266.98M
24 Q2-283.01M
24 Q1-64.19M
EPS (USD) · TTM
024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q24.91
26 Q13.6
25 Q42.11
25 Q32.09
25 Q22.6
25 Q13.15
24 Q42.42
24 Q33.31
24 Q22.74
24 Q12.69
Expenses (USD) · TTM
0200M400M600M800MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2463.52M
26 Q1433.96M
25 Q4394.36M
25 Q3617.37M
25 Q2616.14M
25 Q1615.66M
24 Q4608.81M
24 Q3696.08M
24 Q2682.24M
24 Q1683.07M
Shares Outstanding (USD) · TTM
-50M050M100MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GLP Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q23.58M
26 Q16.25M
25 Q43.18M
25 Q33.57M
25 Q26.37M
25 Q180.25M
24 Q482.39M
24 Q382.23M
24 Q277.14M
24 Q1243K
Dividends (USD)
00.20.40.60.8May 24Aug 24Nov 24Feb 25May 25Aug 25Nov 25Feb 26May 26Aug 26
GLP Dividends (USD) by quarter
PeriodDividends (USD)
Aug 260.78
May 260.77
Feb 260.76
Nov 250.76
Aug 250.75
May 250.74
Feb 250.74
Nov 240.73
Aug 240.72
May 240.71
Employee Count
01K2K3K4K2016201720182019202020212022202320242025
GLP Employee Count by quarter
PeriodEmployee Count
20253.27K
20243.33K
20233.48K
20222.86K
20212.43K
20202.38K
20193.86K
20182.5K
20172K
20161.77K
PE Ratio
7.51012.51517.520med 14.14Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GLP PE Ratio by quarter
PeriodPE Ratio
Sep 2610.06
Sep 2610.38
Sep 2610.37
Aug 269.94
Aug 269.91
Aug 2610
Aug 269.87
Jul 2612.93
Jul 2612.64
Jul 2612.49
Jul 2612.63
Jul 2612.4
Jun 2612.15
Jun 2611.13
Jun 2612.32
Jun 2612.83
May 2612.37
May 2612.97
May 2612.86
May 2612.74
May 2619.8
Apr 2618.75
Apr 2618.49
Apr 2618.58
Apr 2618.19
Mar 2617.94
Mar 2618.85
Mar 2618.79
Mar 2619.24
Feb 2618.99
Feb 2618.8
Feb 2618.9
Feb 2618.2
Jan 2618.31
Jan 2617.17
Jan 2617.2
Jan 2616.53
Jan 2616.39
Dec 2516.51
Dec 2516.75
Dec 2516.99
Dec 2517.39
Nov 2517.05
Nov 2516.29
Nov 2516.85
Nov 2516.35
Oct 2514.06
Oct 2514.24
Oct 2513.98
Oct 2513.64
Oct 2514.45
Sep 2515.55
Sep 2515.31
Sep 2516.26
Sep 2516.01
Aug 2516.52
Aug 2515.85
Aug 2515.55
Aug 2515.62
Aug 2513.24
Jul 2513.25
Jul 2513.23
Jul 2513.29
Jul 2513.52
Jun 2513.49
Jun 2513.87
Jun 2514.22
Jun 2513.77
May 2513.49
May 2513.01
May 2512.67
May 2512.37
May 2516.54
Apr 2516.72
Apr 2516.37
Apr 2515.54
Apr 2515.8
Mar 2517.42
Mar 2517.12
Mar 2517.65
Mar 2517.24
Feb 2518.51
Feb 2514.47
Feb 2514.22
Feb 2514.42
Jan 2513.46
Jan 2512.77
Jan 2513.13
Jan 2511.61
Jan 2511.74
Dec 2411.95
Dec 2411.89
Dec 2413.26
Dec 2414.04
Nov 2414.02
Nov 2413.17
Nov 2412.3
Nov 2412.08
Nov 2413.61
Oct 2413.6
Free Cash Flow Yield
-20%-10%0%10%20%med -4.27%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GLP Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2611.5%
Sep 2611.14%
Sep 2611.15%
Aug 2611.64%
Aug 2611.67%
Aug 2611.56%
Aug 2611.71%
Jul 267.86%
Jul 268.03%
Jul 268.13%
Jul 268.04%
Jul 268.19%
Jun 268.36%
Jun 269.13%
Jun 268.25%
Jun 267.91%
May 268.21%
May 267.83%
May 267.9%
May 267.97%
May 2612%
Apr 2612.68%
Apr 2612.86%
Apr 2612.79%
Apr 2613.07%
Mar 2613.25%
Mar 2612.61%
Mar 2612.65%
Mar 2612.35%
Feb 2612.52%
Feb 26-3.88%
Feb 26-3.86%
Feb 26-4.01%
Jan 26-3.99%
Jan 26-4.25%
Jan 26-4.25%
Jan 26-4.42%
Jan 26-4.46%
Dec 25-4.42%
Dec 25-4.36%
Dec 25-4.3%
Dec 25-4.2%
Nov 25-4.28%
Nov 25-4.48%
Nov 25-4.33%
Nov 25-4.47%
Oct 252.12%
Oct 252.1%
Oct 252.14%
Oct 252.19%
Oct 252.07%
Sep 251.92%
Sep 251.95%
Sep 251.84%
Sep 251.86%
Aug 251.81%
Aug 251.88%
Aug 251.92%
Aug 251.91%
Aug 25-9.02%
Jul 25-9.01%
Jul 25-9.02%
Jul 25-8.99%
Jul 25-8.83%
Jun 25-8.85%
Jun 25-8.61%
Jun 25-8.4%
Jun 25-8.67%
May 25-8.86%
May 25-9.18%
May 25-9.42%
May 25-9.66%
May 25-16.62%
Apr 25-16.44%
Apr 25-16.8%
Apr 25-17.69%
Apr 25-17.4%
Mar 25-15.78%
Mar 25-16.06%
Mar 25-15.58%
Mar 25-15.95%
Feb 25-14.85%
Feb 25-13.57%
Feb 25-13.81%
Feb 25-13.61%
Jan 25-14.59%
Jan 25-15.37%
Jan 25-14.95%
Jan 25-16.91%
Jan 25-16.73%
Dec 24-16.43%
Dec 24-16.51%
Dec 24-14.81%
Dec 24-13.98%
Nov 24-14%
Nov 24-14.91%
Nov 24-15.96%
Nov 24-16.25%
Nov 24-17.8%
Oct 24-17.8%
Price to Sales
0.070.080.090.10.110.12med 0.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GLP Price to Sales by quarter
PeriodPrice to Sales
Sep 260.08
Sep 260.08
Sep 260.08
Aug 260.08
Aug 260.08
Aug 260.08
Aug 260.08
Jul 260.09
Jul 260.08
Jul 260.08
Jul 260.08
Jul 260.08
Jun 260.08
Jun 260.07
Jun 260.08
Jun 260.09
May 260.08
May 260.09
May 260.09
May 260.09
May 260.09
Apr 260.08
Apr 260.08
Apr 260.08
Apr 260.08
Mar 260.08
Mar 260.08
Mar 260.08
Mar 260.09
Feb 260.09
Feb 260.09
Feb 260.09
Feb 260.09
Jan 260.09
Jan 260.08
Jan 260.08
Jan 260.08
Jan 260.08
Dec 250.08
Dec 250.08
Dec 250.08
Dec 250.08
Nov 250.08
Nov 250.08
Nov 250.08
Nov 250.08
Oct 250.09
Oct 250.09
Oct 250.09
Oct 250.08
Oct 250.09
Sep 250.1
Sep 250.09
Sep 250.1
Sep 250.1
Aug 250.1
Aug 250.1
Aug 250.1
Aug 250.1
Aug 250.1
Jul 250.1
Jul 250.1
Jul 250.1
Jul 250.1
Jun 250.1
Jun 250.1
Jun 250.11
Jun 250.1
May 250.1
May 250.1
May 250.09
May 250.09
May 250.1
Apr 250.1
Apr 250.1
Apr 250.09
Apr 250.1
Mar 250.11
Mar 250.1
Mar 250.11
Mar 250.11
Feb 250.11
Feb 250.11
Feb 250.11
Feb 250.11
Jan 250.11
Jan 250.1
Jan 250.1
Jan 250.09
Jan 250.09
Dec 240.09
Dec 240.09
Dec 240.1
Dec 240.11
Nov 240.11
Nov 240.1
Nov 240.1
Nov 240.09
Nov 240.09
Oct 240.09
EV/EBITDA
891011med 9.36Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GLP EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 269.15
Sep 269.29
Sep 269.28
Aug 269.1
Aug 269.09
Aug 269.13
Aug 269.07
Jul 2610.9
Jul 2610.8
Jul 2610.75
Jul 2610.8
Jul 2610.71
Jun 2610.62
Jun 2610.25
Jun 2610.68
Jun 2610.87
May 2610.7
May 2610.92
May 2610.88
May 2610.84
May 269.82
Apr 269.59
Apr 269.53
Apr 269.55
Apr 269.46
Mar 269.41
Mar 269.61
Mar 269.6
Mar 269.7
Feb 269.64
Feb 269.71
Feb 269.73
Feb 269.57
Jan 269.59
Jan 269.33
Jan 269.34
Jan 269.18
Jan 269.15
Dec 259.18
Dec 259.24
Dec 259.29
Dec 259.38
Nov 259.3
Nov 259.13
Nov 259.26
Nov 259.14
Oct 258.78
Oct 258.83
Oct 258.76
Oct 258.67
Oct 258.89
Sep 259.18
Sep 259.12
Sep 259.38
Sep 259.31
Aug 259.45
Aug 259.27
Aug 259.19
Aug 259.2
Aug 259.16
Jul 259.17
Jul 259.16
Jul 259.18
Jul 259.25
Jun 259.24
Jun 259.36
Jun 259.47
Jun 259.33
May 259.24
May 259.09
May 258.99
May 258.89
May 259.62
Apr 259.67
Apr 259.58
Apr 259.36
Apr 259.43
Mar 259.86
Mar 259.78
Mar 259.92
Mar 259.81
Feb 2510.15
Feb 259.8
Feb 259.72
Feb 259.79
Jan 259.47
Jan 259.24
Jan 259.36
Jan 258.85
Jan 258.89
Dec 248.96
Dec 248.94
Dec 249.4
Dec 249.66
Nov 249.65
Nov 249.37
Nov 249.08
Nov 249
Nov 2410.05
Oct 2410.05
Price/Operating Cashflow
020406080med 6.77Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GLP Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 265.34
Sep 265.51
Sep 265.51
Aug 265.28
Aug 265.26
Aug 265.31
Aug 265.24
Jul 267.07
Jul 266.91
Jul 266.83
Jul 266.91
Jul 266.78
Jun 266.64
Jun 266.08
Jun 266.73
Jun 267.02
May 266.76
May 267.09
May 267.03
May 266.97
May 265.71
Apr 265.4
Apr 265.33
Apr 265.35
Apr 265.24
Mar 265.17
Mar 265.43
Mar 265.41
Mar 265.54
Feb 265.47
Feb 266.55
Feb 266.59
Feb 266.34
Jan 266.38
Jan 265.98
Jan 265.99
Jan 265.76
Jan 265.71
Dec 255.75
Dec 255.84
Dec 255.92
Dec 256.06
Nov 255.94
Nov 255.68
Nov 255.87
Nov 255.7
Oct 254.36
Oct 254.42
Oct 254.33
Oct 254.23
Oct 254.48
Sep 254.82
Sep 254.75
Sep 255.04
Sep 254.96
Aug 255.12
Aug 254.92
Aug 254.82
Aug 254.84
Aug 2510.79
Jul 2510.79
Jul 2510.78
Jul 2510.82
Jul 2511.01
Jun 2510.99
Jun 2511.29
Jun 2511.59
Jun 2511.22
May 2510.98
May 2510.59
May 2510.32
May 2510.07
May 2555.92
Apr 2556.52
Apr 2555.32
Apr 2552.53
Apr 2553.41
Mar 2558.87
Mar 2557.87
Mar 2559.66
Mar 2558.27
Feb 2562.58
Feb 2514.38
Feb 2514.13
Feb 2514.34
Jan 2513.38
Jan 2512.7
Jan 2513.05
Jan 2511.54
Jan 2511.67
Dec 2411.88
Dec 2411.82
Dec 2413.18
Dec 2413.96
Nov 2413.94
Nov 2413.09
Nov 2412.23
Nov 2412.01
Nov 2413.96
Oct 2413.95
Price to Book
22.22.42.62.8med 2.34Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GLP Price to Book by quarter
PeriodPrice to Book
Sep 262.32
Sep 262.39
Sep 262.39
Aug 262.29
Aug 262.28
Aug 262.3
Aug 262.27
Jul 262.36
Jul 262.3
Jul 262.28
Jul 262.3
Jul 262.26
Jun 262.21
Jun 262.03
Jun 262.24
Jun 262.34
May 262.25
May 262.36
May 262.34
May 262.32
May 262.45
Apr 262.32
Apr 262.29
Apr 262.3
Apr 262.25
Mar 262.22
Mar 262.33
Mar 262.33
Mar 262.38
Feb 262.35
Feb 262.41
Feb 262.42
Feb 262.33
Jan 262.34
Jan 262.2
Jan 262.2
Jan 262.12
Jan 262.1
Dec 252.11
Dec 252.14
Dec 252.17
Dec 252.23
Nov 252.18
Nov 252.09
Nov 252.16
Nov 252.09
Oct 252.23
Oct 252.26
Oct 252.22
Oct 252.17
Oct 252.3
Sep 252.47
Sep 252.43
Sep 252.58
Sep 252.54
Aug 252.62
Aug 252.52
Aug 252.47
Aug 252.48
Aug 252.51
Jul 252.51
Jul 252.51
Jul 252.52
Jul 252.57
Jun 252.56
Jun 252.63
Jun 252.7
Jun 252.61
May 252.56
May 252.47
May 252.4
May 252.35
May 252.41
Apr 252.44
Apr 252.39
Apr 252.27
Apr 252.31
Mar 252.54
Mar 252.5
Mar 252.58
Mar 252.52
Feb 252.7
Feb 252.72
Feb 252.67
Feb 252.71
Jan 252.53
Jan 252.4
Jan 252.47
Jan 252.18
Jan 252.21
Dec 242.25
Dec 242.24
Dec 242.49
Dec 242.64
Nov 242.64
Nov 242.48
Nov 242.31
Nov 242.27
Nov 242.25
Oct 242.25
Global Partners LP
GLP
Stockpicker

Video analysis: GLP

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: GLP

4 Solid Shareholder Yield Stocks That Can Beat Rising Treasury Yields

zacks.com · 15 Sep 2026

4 Solid Shareholder Yield Stocks That Can Beat Rising Treasury Yields

Shareholder yield can offer growing cash flows and total-return potential as Treasury yields rise, with BP, CIB, GLP and PBI standing out.

Are Investors Undervaluing Global Partners (GLP) Right Now?

zacks.com · 15 Sep 2026

Are Investors Undervaluing Global Partners (GLP) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It

accessnewswire.com · 15 Sep 2026

The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It

Company plans to integrate telemedicine into its verified health intelligence platform and opens a ten-seat Founding Physician Cohort spanning GLP-1 and metabolic care, hormone and menopause health, and physician-directed therapies for men and women. MIAMI, FL / ACCESS Newswire / September 15, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced plans to integrate telemedicine capabilities into its verified health intelligence platform and opened applications for its Founding Physician Cohort.

Making Getting Skinny Taste Good: Cava CEO On The GLP-1 Boom

youtube.com · 11 Sep 2026

Making Getting Skinny Taste Good: Cava CEO On The GLP-1 Boom

From smaller portions and adults ordering kids meals to more protein and Mediterranean-style eating, Cava CEO Brett Schulman breaks down how GLP-1s are changing customer behavior. Check out our daily newsletter!

Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s

zacks.com · 11 Sep 2026

Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s

LLY's immunology portfolio is gaining ground, with steady revenue growth, pipeline expansion and acquisitions broadening its next wave.

‘US Consumption of Alcoholic Beverages Is at Historic Lows': Heineken Hires GLP-1 Pitchwoman to Sell Beer

247wallst.com · 10 Sep 2026

‘US Consumption of Alcoholic Beverages Is at Historic Lows': Heineken Hires GLP-1 Pitchwoman to Sell Beer

Heineken's US chief executive Maggie Timoney went on Bloomberg this week to explain why Serena Williams was named the first global ambassador for Heineken 0.

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

benzinga.com · 9 Sep 2026

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

MannKind Corporation (NASDAQ:MNKD) shares are trading lower on Wednesday as traders react to the company's entry into a licensing and collaboration deal tied to an inhaled, rapid-acting GLP-1 program.

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program

globenewswire.com · 9 Sep 2026

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program

SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, announced a new, independent cost savings model that examined the measurable clinical and economic value of Omada's GLP-1 program.1 GlobalData , a data analytics and consulting company, recently published a report estimating greater disease reduction and higher cumulative cost savings with Omada's GLP-1 solutions compared to standard care.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.